Public Release: 

Brain scans help unravel the neurobiology of functional neurological (conversion) disorder

Mass. General study finds altered connectivity among brain structures handling sensorimotor, emotional and cognitive signaling

Massachusetts General Hospital

An investigation led by a team of researchers from the Massachusetts General Hospital (MGH) departments of Neurology, Psychiatry and Radiology has found altered connectivity among brain regions that handle sensorimotor, emotional and cognitive signaling in patients with functional neurological disorder, a common condition involving neurologic symptoms that have no readily apparent physical cause. Their report has been published online in the Journal of Neurology, Neurosurgery and Psychiatry.

"The mechanistic understanding of functional neurological disorder is in its infancy compared to other major neurologic or psychiatric conditions," says David Perez, MD, MMsc, of the MGH Departments of Neurology and Psychiatry, who leads the hospital's Functional Neurology Research Group, and is co-senior author of the current paper. "Our previous work found that structural changes in the insula - a brain structure that may be involved with self- and emotional awareness - correlated with physical disability in patients with functional neurological disorder. In this study we also were able to demonstrate a similar correlation of symptom severity with the flow of information between the left insula and other areas involved in awareness and bodily perceptual processing."

Functional neurological disorder (FND) involves symptoms such as tremors, weakness, seizures, and trouble walking that cannot be explained by traditional neurologic diagnoses. Previously believed to be the result of patients' converting emotional distress into physical symptoms - leading to the name 'conversion disorder' - FND has been shown by Perez's team and others to involve altered activity of brain structures involved with emotional processing and motor control. The current study was designed to investigate precisely how communication is changed between these structures in patients with FND and how patterns of brain activity relate to symptom severity.

To do so, the research team used an MRI-based approach developed by co-senior author Jorge Sepulcre, MD, PhD, DMSc, of the Gordon Center for Medical Imaging at MGH, to examine the functional connectivity - a measure of the coupling and coordination of neural signals - between brain structures involved in processing emotional or motor signals and a set of areas called the multimodal integration network, which Sepulcre and others have previously characterized as integrating sensorimotor, cognitive and emotional information.

The results of the study, which compared 30 patients with FND to 30 healthy controls, indicated increased connectivity between motor regions and several portions of the multimodal integration network among FND patients. Not only did symptom severity correlate with increased connectivity between specific network structures, but the study revealed - for the first time - that increased coupling between the insula and the amygdala, a structure key to emotional processing, correlated with improved response to treatment.

"While this is an early study that warrants replication, it is an important advance in bridging the gap between understanding the biology of FND and improving the lives of patients with this disorder," says Perez, an assistant professor of Neurology at Harvard Medical School (HMS). "As a next step, we are planning to collect brain scan data taken before and after patients are treated, which should allow us to more closely examine structural and functional brain changes that relate to clinical improvement."

###

Along with Sepulcre, an assistant professor of Radiology at HMS, the co-authors of the Journal of Neurology, Neurosurgery and Psychiatry paper are lead author Ibai Diez, PhD, MGH Neurology and Radiology; Laura Ortiz-Terán, Benjamin Williams, Rozita Jalilianhasanpour, MD, Juan Pablo Ospina, MD, and Bradford Dickerson MD, MGH Neurology; Matcheri Keshavan, MD, Beth Israel Deaconess Medical Center; and W. Curt LaFrance Jr., MD, MPH, Alpert Medical School, Brown University. Support for the study includes National Institute of Mental Health grant K23 MH111983-02 and a grant from the Sidney R. Baer Jr. Foundation.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $925 million and major research centers in HIV/AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, genomic medicine, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, photomedicine and transplantation biology. The MGH topped the 2015 Nature Index list of health care organizations publishing in leading scientific journals and earned the prestigious 2015 Foster G. McGaw Prize for Excellence in Community Service. In August 2018 the MGH was once again named to the Honor Roll in the U.S. News & World Report list of "America's Best Hospitals."

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.